D. Palmer

421 total citations
18 papers, 275 citations indexed

About

D. Palmer is a scholar working on Oncology, Epidemiology and Surgery. According to data from OpenAlex, D. Palmer has authored 18 papers receiving a total of 275 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in D. Palmer's work include Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Colorectal Cancer Treatments and Studies (2 papers). D. Palmer is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Colorectal Cancer Treatments and Studies (2 papers). D. Palmer collaborates with scholars based in United Kingdom, United States and Germany. D. Palmer's co-authors include Syed A. Hussain, C. A. Hart, Rachel L. Graham, Min Chen, Francesco S. Celi, Jean B. Regard, Michael T. Collins, Jean‐Marc Guettier, Jawaher Ansari and Natasha Cherman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Journal of Hepatology.

In The Last Decade

D. Palmer

16 papers receiving 271 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Palmer United Kingdom 8 117 60 41 41 36 18 275
Francesca Ambrogio Italy 11 65 0.6× 65 1.1× 50 1.2× 26 0.6× 15 0.4× 60 268
Yingcheng Zheng China 12 224 1.9× 50 0.8× 69 1.7× 61 1.5× 18 0.5× 30 455
Chaoying Zhou China 13 170 1.5× 79 1.3× 16 0.4× 26 0.6× 21 0.6× 32 453
Wen Shi China 13 95 0.8× 52 0.9× 19 0.5× 11 0.3× 29 0.8× 21 387
Reiko Akitake Japan 6 145 1.2× 80 1.3× 55 1.3× 83 2.0× 37 1.0× 7 344
Eun Byul Cho South Korea 13 60 0.5× 32 0.5× 16 0.4× 24 0.6× 28 0.8× 40 437
Hiroo Amano Japan 13 82 0.7× 57 0.9× 30 0.7× 43 1.0× 37 1.0× 48 437
Jorge Postigo Spain 12 97 0.8× 51 0.8× 11 0.3× 26 0.6× 20 0.6× 24 388
Alba Llibre France 10 105 0.9× 55 0.9× 12 0.3× 16 0.4× 21 0.6× 21 390
Eleanor Lynam United Kingdom 3 84 0.7× 46 0.8× 18 0.4× 12 0.3× 26 0.7× 5 277

Countries citing papers authored by D. Palmer

Since Specialization
Citations

This map shows the geographic impact of D. Palmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Palmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Palmer more than expected).

Fields of papers citing papers by D. Palmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Palmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Palmer. The network helps show where D. Palmer may publish in the future.

Co-authorship network of co-authors of D. Palmer

This figure shows the co-authorship network connecting the top 25 collaborators of D. Palmer. A scholar is included among the top collaborators of D. Palmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Palmer. D. Palmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Fernandes, Carlos, Alan Wang, D. Palmer, et al.. (2025). The vector-pathogen anti-complement evolution dictates host skin immunomodulation for multimodal Lyme disease bacterial transmission. Immunobiology. 230(4). 152920–152920.
2.
Jackson, Richard, Michael C. Schmid, Ainhoa Mielgo, et al.. (2025). Neoadjuvant treatment versus upfront surgery in borderline resectable and resectable pancreatic ductal adenocarcinoma: meta-analysis. BJS Open. 9(2). 2 indexed citations
3.
Kassab, Mohamad, Charmaine Matthews, James M. Fox, et al.. (2024). Lower hepatocellular carcinoma surveillance in metabolic dysfunction‐associated steatotic liver disease: Impact on treatment eligibility. Journal of Gastroenterology and Hepatology. 39(12). 2817–2825. 4 indexed citations
4.
Savadipour, Alireza, et al.. (2023). The role of PIEZO ion channels in the musculoskeletal system. American Journal of Physiology-Cell Physiology. 324(3). C728–C740. 46 indexed citations
5.
Kudo, Masatoshi, Richard S. Finn, Shukui Qin, et al.. (2022). Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study. Journal of Hepatology. 78(1). 133–141. 27 indexed citations
6.
7.
Mu, Song, D. Palmer, Richard J. Fitzgerald, et al.. (2021). Human Mass Balance and Metabolite Profiling of [14C]‐Pamiparib, a Poly (ADP‐Ribose) Polymerase Inhibitor, in Patients With Advanced Cancer. Clinical Pharmacology in Drug Development. 10(9). 1108–1120. 5 indexed citations
8.
Toyoda, Hideki, Takashi Kumada, Nóra Schweitzer, et al.. (2017). Prognostic impact of serum alpha-fetoprotein in patients with hepatocellular carcinoma: an international collaborative study. Journal of Hepatology. 66(1). S620–S621. 1 indexed citations
9.
Clough, Bret H., Eoin P. McNeill, D. Palmer, et al.. (2016). An allograft generated from adult stem cells and their secreted products efficiently fuses vertebrae in immunocompromised athymic rats and inhibits local immune responses. The Spine Journal. 17(3). 418–430. 14 indexed citations
10.
Sutton, Paul, Robert Jones, Christopher E. Goldring, et al.. (2015). Evaluation of a novel tissue stabilization gel to facilitate clinical sampling for translational research in surgical trials. British journal of surgery. 102(2). e124–e132. 2 indexed citations
11.
Berhane, Sarah, Shinji Satomura, Takashi Kumada, et al.. (2014). O110 AN INTERNATIONAL COLLABORATIVE STUDY ASSESSING THE ROLE OF AETIOLOGY AND STAGE IN SURVIVAL IN HCC – IMPLICATIONS FOR SCREENING. Journal of Hepatology. 60(1). S45–S46. 8 indexed citations
12.
Regard, Jean B., Natasha Cherman, D. Palmer, et al.. (2011). Wnt/β-catenin signaling is differentially regulated by Gα proteins and contributes to fibrous dysplasia. Proceedings of the National Academy of Sciences. 108(50). 20101–20106. 85 indexed citations
13.
Palmer, D., Syed A. Hussain, Anna Jo Bodurtha Smith, David Hull, & P. J. Johnson. (2010). Sorafenib for advanced hepatocellular carcinoma (HCC): Impact of rationing in the United Kingdom.. Journal of Clinical Oncology. 28(15_suppl). e14516–e14516. 1 indexed citations
14.
Ansari, Jawaher, D. Palmer, D. Rea, & Syed A. Hussain. (2009). Role of Tyrosine Kinase Inhibitors in Lung Cancer. Anti-Cancer Agents in Medicinal Chemistry. 9(5). 569–575. 25 indexed citations
15.
Hussain, Syed A., Yuk Ting, D. Palmer, Paul Hutton, & Michael Cullen. (2008). Biology of testicular germ cell tumors. Expert Review of Anticancer Therapy. 8(10). 1659–1673. 16 indexed citations
16.
Giulivi, Antonio, et al.. (1998). Clinical Usefulness of Flow Cytometry in Detection and Quantification of Fetomaternal Hemorrhage.. PubMed. 8(3). 121–125. 6 indexed citations
17.
Graham, Rachel L., et al.. (1988). In vitro activity of florphenicol. European Journal of Clinical Microbiology & Infectious Diseases. 7(5). 691–694. 31 indexed citations
18.
Pohlenz, Joachim, et al.. (1979). [Pathology and pathogenesis of neonatal diarrhea in the calf. I. Presentation of the problem and a discussion of its etiology and pathogenesis based on the latest literature].. PubMed. 121(12). 607–14. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesca Ambrogio Breakdown of academic impact, for papers by Yingcheng Zheng Breakdown of academic impact, for papers by Chaoying Zhou Breakdown of academic impact, for papers by Wen Shi Breakdown of academic impact, for papers by Reiko Akitake Breakdown of academic impact, for papers by Eun Byul Cho Breakdown of academic impact, for papers by Hiroo Amano Breakdown of academic impact, for papers by Jorge Postigo Breakdown of academic impact, for papers by Alba Llibre Breakdown of academic impact, for papers by Eleanor Lynam
Rankless by CCL
2026